Genfit (GNFTF) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free GNFTF Stock Alerts $2.95 0.00 (0.00%) (As of 04/23/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGenfit (OTC: GNFTF)fool.com - April 16 at 9:48 AMInventiva resumes Phase 3 study for NASH drug, stock up 6%msn.com - March 8 at 2:24 PMOptimistic Outlook for Genfit: Justine Telliez Raises Target Price Amid Positive Drug Developmentsmarkets.businessinsider.com - December 11 at 5:40 PMBuy Rating Affirmed for Genfit SA on Strong Elafibranor Efficacy and Favorable Regulatory Prospectsmarkets.businessinsider.com - December 9 at 6:15 AMGENFIT Updates 2024 Outlook Following Acceptance of Elafibranor Filings in Primary Biliary Cholangitis (PBC)markets.businessinsider.com - December 8 at 5:47 AMGenfit Share Price (GNFT.PA)lse.co.uk - November 15 at 10:43 PMIpsen, Genfit Drug Fights Liver Disease Progression, Phase-Three Trial Findsmarketwatch.com - November 14 at 8:23 AMGenfit reports 9M resultsseekingalpha.com - November 12 at 10:53 PMKepler Capital Sticks to Their Buy Rating for Genfit (GNFTF)markets.businessinsider.com - September 23 at 12:36 AMSVB Securities Remains a Buy on Genfit SA (GNFT)markets.businessinsider.com - July 4 at 5:37 PMGenfit Shares Jump 27% After Positive Phase 3 Trial Resultsmarketwatch.com - June 30 at 8:05 AMU.S.-listed shares of Genfit soar 24% after positive results from late-stage trial of treatment for rare type of liver diseasemsn.com - June 30 at 8:05 AMGenfit Gears Up For Primary Biliary Cholangitis Trial Datamarkets.businessinsider.com - June 7 at 10:29 AMGenfit (GNFTF) Receives a Buy from Kepler Capitalmarkets.businessinsider.com - June 3 at 1:36 AMODDO BHF Maintains Genfit (EPA:GNFT) Buy Recommendationmsn.com - April 21 at 6:16 PMSVB SECURITIES Maintains Genfit (EPA:GNFT) Outperform Recommendationmsn.com - April 21 at 6:16 PMGENFIT Announces 2023 Financial Calendarbenzinga.com - January 24 at 5:48 PMA Long Wait For Genfit May Be Worth Itseekingalpha.com - November 23 at 10:55 AMGENFIT Announces Signature of the Share Purchase Agreement and the Completion of its Acquisition of Versantisnz.finance.yahoo.com - September 29 at 4:36 PMGENFIT to Acquire Clinical-stage Biopharmaceutical Company Versantis, expanding its Portfolio in Liver Diseasesfinance.yahoo.com - September 19 at 4:15 AMGenfit Tortures Fatty Liver Drug to Extract Positive Results From Failed Studythestreet.com - September 14 at 9:02 AMFDA Grants GENFIT’s GNS561 Orphan Drug Designation for the Treatment of Cholangiocarcinomafinance.yahoo.com - September 13 at 6:00 PMGenfit's French Fans Fume Following Failure of Fatty Liver Drugthestreet.com - September 12 at 9:57 PMGenfit S.A. (GNFT)finance.yahoo.com - September 9 at 4:47 PMGNFT.OQ - Genfit SA (ADR) | Stock Price & Latest News | Reutersreuters.com - August 20 at 8:31 PMAnalyzing Genfit's Short Interestmsn.com - August 19 at 1:57 PMNew Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The ...apnews.com - November 3 at 9:48 AMNew Clinical Data on GENFIT’s Investigational Compound Elafibranor to be Presented at AASLD The Liver Meeting®finance.yahoo.com - November 2 at 7:10 PM Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… GNFTF Media Mentions By Week GNFTF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNFTF News Sentiment▼0.000.44▲Average Medical News Sentiment GNFTF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNFTF Articles This Week▼00▲GNFTF Articles Average Week Get Genfit News Delivered to You Automatically Sign up to receive the latest news and ratings for GNFTF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News Today ALK-Abelló A/S News Today Alpha Tau Medical News Today Arno Therapeutics News Today Artelo Biosciences News Today Ascletis Pharma News Today Awakn Life Sciences News Today AXIM Biotechnologies News Today BerGenBio ASA News Today BriaCell Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:GNFTF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Goldtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genfit S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
